Cor Vasa 2023, 65(6):877-879 | DOI: 10.33678/cor.2023.021
Coronary evagination after self-apposing stent deployment: a rare but possible event. A clinical case at 4-year follow-up
- a Department of Cardiothoracic and Vascular Science, Division of Cardiology, Papardo Hospital, Messina, Italy
- b Department of Clinical and Experimental Medicine, University of Messina, Italy
Background: Coronary evagination is a coronary abnormality that has been associated with poor long-term outcomes irrespective of the presence of concomitant coronary artery disease (CAD). Its pathogenesis is still not well understood; intracoronary manipulation and percutaneous coronary intervention (PCI) are considered predictors of coronary enlargement through mechanism such as prolonged inflammation, suboptimal endothelialization and vessel positive remodeling. Some stent platforms, like self-apposing stents, seem to be more involved, causing more vessel remodeling. Case presentation: We report the case of a 79-year-old woman who underwent percutaneous coronary intervention (PCI) because of effort angina pectoris; we used a self-apposing stent in a slightly ectatic segment of left circumflex artery and a conventional stent to treat another lesion, with good results. Four years later, a coronary angiography showed an aneurysm surrounding previously implanted self-apposing stent platform; anyway, the coronary flow was normal, so no further intervention was required.
Conclusions: To the best of our knowledge, this is the first paper considering the implication of self-apposing stent properties in evagination generation; this clinical case can be useful to pay attention to patients who underwent percutaneous coronary intervention and received this type of stent.
Keywords: Coronary angiography, Coronary evagination, Self-apposing stent
Received: March 9, 2023; Revised: March 9, 2023; Accepted: March 16, 2023; Prepublished online: June 2, 2012; Published: December 22, 2023 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- Kawsara A, Núñez Gil IJ, Alqahtani F, et al, Management of Coronary Artery Aneurysms. JACC Cardiovasc Interv 2018;11:1211-1223.
Go to original source...
Go to PubMed...
- Fitzgerald PJ, Otake H. Evaluation of Vessel Response to Percutaneous Coronary Intervention. Rev Española Cardiol (English Ed.) 2008;61:1001-1006.
Go to original source...
- Radu MD, Räber L, Kalesan B, et al. Coronary evaginations are associated with positive vessel remodelling and are nearly absent following implantation of newer-generation drug-eluting stents: An optical coherence tomography and intravascular ultrasound study. Eur Heart J 2014;35:795-807.
Go to original source...
Go to PubMed...
- Pellegrini D, Cortese B. Focus on STENTYS® Xposition S Self-Apposing® stent: A review of available literature, Future Cardiol 2019;15:145-159.
Go to original source...
Go to PubMed...
- Morabito C, Casale M, Crea P, et al. Atrial fibrillation and thrombophilia. DOAC as a valid alternative? A clinical case. Cor Vasa 2020;62:470-472.
Go to original source...
- Dattilo G, Borgia F, Guarneri C, et al. Cardiovascular Risk in Psoriasis: Current State of the Art. Curr Vasc Pharmacol 2019;17:85-91.
Go to original source...
Go to PubMed...
- Casale M, Dattilo G, Imbalzano E, et al. The thromboembolism in COVID-19: the unsolved problem. Panminerva Med 2023;65:51-57.
Go to original source...
Go to PubMed...
- Wilson GJ, Nakazawa G, Schwartz RS, et al. Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries. Circulation 2009;120:141-149.
Go to original source...
Go to PubMed...
- Nakazawa G, Finn AV, Vorpahl M, et al. Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stents. J Am Coll Cardiol 2011;57:390-398.
Go to original source...
Go to PubMed...
- Otsuka F, Vorpahl M, Nakano M, et al. Pathology of Second-Generation Everolimus-Eluting Stents Versus First-Generation Sirolimus- and Paclitaxel-Eluting Stents in Humans. Circulation 2014;129:211-223.
Go to original source...
Go to PubMed...
- John MC, Wessely R, Kastrati A, et al. Differential Healing Responses in Polymer- and Nonpolymer-Based Sirolimus-Eluting Stents. JACC Cardiovasc Interv 2008;1:535-544.
Go to original source...
Go to PubMed...
- Virmani R, Guagliumi G, Farb A, et al. Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting Stent. Circulation 2004;109:701-705.
Go to original source...
Go to PubMed...
- Kleber FX, Schulz A, Köln P. Positive Vessel Remodelling. Eur Med J 2018;111-115.
Go to original source...
- Bitto R, Casale M, Morabito C, et al. Takotsubo Cardiomyopathy: a Benign Condition or a Bad Omen? Angiology 2018;69:100-102.
Go to original source...
Go to PubMed...
- Corrado E, Dattilo G, Coppola G, et al. Low- vs high-dose ARNI effects on clinical status, exercise performance and cardiac function in real-life HFrEF patients. Eur J Clin Pharmacol 2022;78:19-25.
Go to original source...
Go to PubMed...
- Dattilo G, Bitto R, Correale M, et al. Trend of perceived quality of life and functional capacity in outpatients with chronic heart failure and in treatment with sacubitril/valsartan: a real-life experience. Minerva Cardiol Angiol 2022;70:555-562.
Go to original source...
Go to PubMed...
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.